/publications/medicare-price-negotiation-and-pharmaceutical-innovation-following-inflation-reduction
The Inflation Reduction Act (IRA) requires Medicare to negotiate lower prices for some medicines with high Medicare spending. Using…
Are application hassles, or “ordeals,” an effective way to limit public program enrollment? We provide new evidence by studying (removal of…
The United States spends substantially more on health care than most developed countries, yet leaves a greater share of the population…
Insurance markets often feature consumer sorting along both an extensive margin (whether to buy) and an intensive margin (which plan to buy…
The US spends substantially more on health care per capita than other high-income countries yet leaves a greater share of the population…
Regulators of new products confront a tradeoff between speeding a new product to market and collecting additional product quality…
Health plans for the poor increasingly limit access to specialty hospitals. We investigate the role of adverse selection in generating this…
One of our great urbanists and one of our great public health experts join forces to reckon with how cities are changing in the face of…
/publications/do-insurers-respond-active-purchasing-evidence-massachusetts-health-insurance-exchange
As the ACA Marketplaces face challenges with high premiums and limited insurer competition, there is significant interest in how…
There is growing interest in market design using default rules and other "choice architecture" principles to steer consumers toward…